Your browser doesn't support javascript.
loading
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
van Ruiten, Charlotte C; van der Aart-van der Beek, Annemarie B; IJzerman, Richard G; Nieuwdorp, Max; Hoogenberg, Klaas; van Raalte, Daniël H; Heerspink, Hiddo J L.
Afiliação
  • van Ruiten CC; Diabetes Centre, Department of Internal Medicine, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands.
  • van der Aart-van der Beek AB; Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.
  • IJzerman RG; Clinical Pharmacy, Martini Hospital, Groningen, The Netherlands.
  • Nieuwdorp M; Diabetes Centre, Department of Internal Medicine, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands.
  • Hoogenberg K; Diabetes Centre, Department of Internal Medicine, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands.
  • van Raalte DH; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.
  • Heerspink HJL; Diabetes Centre, Department of Internal Medicine, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands.
Diabetes Obes Metab ; 23(8): 1851-1858, 2021 08.
Article em En | MEDLINE | ID: mdl-33908691
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article